11/26
08:06 am
aura
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference [Yahoo! Finance]
Medium
Report
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference [Yahoo! Finance]
11/26
08:00 am
aura
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Medium
Report
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference
11/14
08:15 am
aura
Aura Biosciences, Inc. (NASDAQ: AURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Medium
Report
Aura Biosciences, Inc. (NASDAQ: AURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
11/12
04:05 pm
aura
Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights
Medium
Report
Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights
10/21
03:13 pm
aura
Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value [Seeking Alpha]
Neutral
Report
Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value [Seeking Alpha]
10/18
03:33 pm
aura
Aura Biosciences, Inc. (NASDAQ: AURA) had its "buy" rating re-affirmed by analysts at Cowen Inc.
Low
Report
Aura Biosciences, Inc. (NASDAQ: AURA) had its "buy" rating re-affirmed by analysts at Cowen Inc.
10/18
11:53 am
aura
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at Scotiabank from $20.00 to $23.00. They now have a "sector outperform" rating on the stock.
Low
Report
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at Scotiabank from $20.00 to $23.00. They now have a "sector outperform" rating on the stock.
10/18
11:01 am
aura
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at BTIG Research from $21.00 to $24.00. They now have a "buy" rating on the stock.
Low
Report
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at BTIG Research from $21.00 to $24.00. They now have a "buy" rating on the stock.
10/18
08:33 am
aura
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at HC Wainwright from $21.00 to $22.00. They now have a "buy" rating on the stock.
Low
Report
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at HC Wainwright from $21.00 to $22.00. They now have a "buy" rating on the stock.
10/17
04:05 pm
aura
Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial
High
Report
Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial
10/4
08:16 am
aura
Aura Biosciences, Inc. (NASDAQ:AURA) is a favorite amongst institutional investors who own 58% [Yahoo! Finance]
Low
Report
Aura Biosciences, Inc. (NASDAQ:AURA) is a favorite amongst institutional investors who own 58% [Yahoo! Finance]